FDA approves Revolution Medicines’ first in class targeted therapy for metastatic pancreatic cancer
67,000 new cases of pancreatic cancer are diagnosed in the US each year
Read More
Aug 27, 2026 | News, Regulatory
67,000 new cases of pancreatic cancer are diagnosed in the US each year
Read MoreAround 112,000 new cases of skin cancer will be diagnosed in the US in 2026
Read MoreAug 25, 2026 | News, Healthcare
This is to expand access to leukaemia treatment in low- and middle-income countries
Read MoreThe company will pay $435m in up front and near-term milestone payments
Read MoreResearchers have created the first multi-responsive gel built from ‘foldamers’ – a discovery that could lead to smart sensors, switchable catalysts and more
Read MoreThe mRNA-based therapy, used with Keytruda, is designed specifically for each patient
Read MoreAug 19, 2026 | News, Regulatory
Excessive sweating affects 1-5% of the population and can have a substantial impact on quality of life
Read MoreAug 18, 2026 | News, Regulatory
There are currently no approved human vaccines for Lyme disease
Read MoreAug 17, 2026 | News, Healthcare
The agreement for up to ten biosimilar assets represents one of largest ever biosimilar collaborations for the company
Read MoreAug 14, 2026 | News, Healthcare
Texas has been chosen as the site for a new, state-of-the-art multi-modal manufacturing campus
Read MoreAug 13, 2026 | News, Regulatory
The treatment uses peptides designed to retrain the immune system to tolerate peanuts
Read MoreAug 12, 2026 | News, Regulatory
NETs affect approximately seven per 100,000 people in Scotland
Read More
